BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hyeon JW, Noh R, Choi J, Lee SM, Lee YS, An SSA, No KT, Lee J. BMD42-2910, a Novel Benzoxazole Derivative, Shows a Potent Anti-prion Activity and Prolongs the Mean Survival in an Animal Model of Prion Disease. Exp Neurobiol 2020;29:93-105. [PMID: 32122111 DOI: 10.5607/en.2020.29.1.93] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Guzow K, Mulkiewicz E, Obuchowski M, Wiczk W. Biological activity of 3-(2-benzoxazol-5-yl)alanine derivatives. Amino Acids 2021;53:1257-68. [PMID: 34240252 DOI: 10.1007/s00726-021-03030-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gielnik M, Zhukova L, Zhukov I, Gräslund A, Kozak M, Wärmländer SK. The engineered peptide construct NCAM1-Aβ inhibits aggregation of the human prion protein (PrP).. [DOI: 10.1101/2021.01.04.425177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]